CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac’s Diagnostics business unit today announced launch of its advanced Next Generation Sequencing (NGS) data Analysis services.
These latest enhancements to Almac’s service portfolio include a comprehensive range of NGS solutions from professional study design to sample processing and expert data analysis for DNA and RNA samples. Uniquely, the services are highly customizable and are available on a standalone basis or in combination with Almac’s established bioinformatics offerings in the areas of biological analysis, biomarker and drug discovery and development and diagnostic product development. Almac will utilize the latest sequencing technologies and most sophisticated modern computational analysis techniques to ensure optimal results from customer data.
